Araştırma Makalesi

Are serum GRP78 levels significant in chronic hepatitis C patients? A case-control study

Cilt: 3 Sayı: 12 3 Aralık 2019
PDF İndir
TR EN

Are serum GRP78 levels significant in chronic hepatitis C patients? A case-control study

Öz

Aims: Glucose-regulated protein 78 (GRP-78) is one of the basic markers of endoplasmic reticulum (ER) stress in tissues. It is known that ER stress develops in the livers of patients infected with hepatitis C. In this study, the aim was to assess serum GRP78 levels which have not previously been investigated as a stress marker in chronic hepatitis C patients (CHC).

Methods: This case control study includes patients with chronic hepatitis C (CHC) infection in our Infectious Diseases clinic (n=60) and a healthy control group without any additional chronic disease (n=60). Serum GRP78 levels were measured with enzyme-linked immunosorbent assay (ELISA), then correlation analysis was performed for serum GRP78 levels with alanine aminotransferase (ALT), aspartate aminotransferase (AST) and HCV-RNA levels.

Results: A significant positive correlation was observed between HCV-RNA, ALT and AST levels in CHC patients (P<0.001 and P=0.008, respectively). Serum GRP78 was identified at similar levels in both the control and HCV subgroups. While a significant positive correlation was identified between serum GRP78 and AST levels (P=0.046), no significant correlation was detected for serum ALT levels.

Conclusion: Though liver injury induced by HCV is shown to cause ER stress, our results showed there was no significant increase in serum GRP78 levels during chronic HCV infection.

Anahtar Kelimeler

Destekleyen Kurum

The authors declared that this study has received financial support from the Ordu University Scientific Research Project Fund

Proje Numarası

BAP; HD-1722

Kaynakça

  1. 1. Hanafiah KM, Groeger J, Flaxman AD, Wiersma ST. Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence. Hepatology. 2013;57(4):1333-42.
  2. 2. Messina JP, Humphreys I, Flaxman A, Brown A, Cooke GS, Pybus OG et al. Global distribution and prevalence of hepatitis C virus genotypes. Hepatology. 2015;61:77-87.
  3. 3. Razavi H, Elkhoury AC, Elbasha E, Estes C, Pasini K, Poynard T, et al. Chronic hepatitis C virus (HCV) disease burden and cost in the United States. Hepatology. 2013;57:2164-70.
  4. 4. El-Serag HB, Kanwal F, Davila JA, Kramer J, Richardson P. A new laboratory-based algorithm to predict development of hepatocellular carcinoma in patients with hepatitis C and cirrhosis. Gastroenterology. 2014;146:1249-55.
  5. 5. El-Serag HB. Epidemiology of viral hepatitis and hepatocellular carcinoma. Gastroenterology. 2012;142:1264-73.
  6. 6. Düzgün A, Alaçam H, Okuyucu A. Endoplasmic reticulum stress and unfolded protein response. J Exp Clin Med. 2012;29:95-100.
  7. 7. Asselah T, Bieche I, Mansouri A, Laurendeau I, Cazals-Hatem D, Feldmann G, et al. In vivo hepatic endoplasmic reticulum stress in patients with chronic hepatitis C. J Pathol. 2010;221(3):264-74.
  8. 8. Welihinda AA, Tirasophon W, Kaufman RJ. The cellular response to protein misfolding in the endoplasmic reticulum. Gene Expression. 1999;7:293-300.

Ayrıntılar

Birincil Dil

İngilizce

Konular

Bulaşıcı Hastalıklar

Bölüm

Araştırma Makalesi

Yayımlanma Tarihi

3 Aralık 2019

Gönderilme Tarihi

23 Temmuz 2019

Kabul Tarihi

23 Aralık 2019

Yayımlandığı Sayı

Yıl 2019 Cilt: 3 Sayı: 12

Kaynak Göster

APA
Altunçekiç Yıldırım, A., Cırrık, S., Çetinkol, Y., Çalgın, M. K., & Noyan, T. (2019). Are serum GRP78 levels significant in chronic hepatitis C patients? A case-control study. Journal of Surgery and Medicine, 3(12), 852-855. https://doi.org/10.28982/josam.595537
AMA
1.Altunçekiç Yıldırım A, Cırrık S, Çetinkol Y, Çalgın MK, Noyan T. Are serum GRP78 levels significant in chronic hepatitis C patients? A case-control study. J Surg Med. 2019;3(12):852-855. doi:10.28982/josam.595537
Chicago
Altunçekiç Yıldırım, Arzu, Selma Cırrık, Yeliz Çetinkol, Mustafa Kerem Çalgın, ve Tevfik Noyan. 2019. “Are serum GRP78 levels significant in chronic hepatitis C patients? A case-control study”. Journal of Surgery and Medicine 3 (12): 852-55. https://doi.org/10.28982/josam.595537.
EndNote
Altunçekiç Yıldırım A, Cırrık S, Çetinkol Y, Çalgın MK, Noyan T (01 Aralık 2019) Are serum GRP78 levels significant in chronic hepatitis C patients? A case-control study. Journal of Surgery and Medicine 3 12 852–855.
IEEE
[1]A. Altunçekiç Yıldırım, S. Cırrık, Y. Çetinkol, M. K. Çalgın, ve T. Noyan, “Are serum GRP78 levels significant in chronic hepatitis C patients? A case-control study”, J Surg Med, c. 3, sy 12, ss. 852–855, Ara. 2019, doi: 10.28982/josam.595537.
ISNAD
Altunçekiç Yıldırım, Arzu - Cırrık, Selma - Çetinkol, Yeliz - Çalgın, Mustafa Kerem - Noyan, Tevfik. “Are serum GRP78 levels significant in chronic hepatitis C patients? A case-control study”. Journal of Surgery and Medicine 3/12 (01 Aralık 2019): 852-855. https://doi.org/10.28982/josam.595537.
JAMA
1.Altunçekiç Yıldırım A, Cırrık S, Çetinkol Y, Çalgın MK, Noyan T. Are serum GRP78 levels significant in chronic hepatitis C patients? A case-control study. J Surg Med. 2019;3:852–855.
MLA
Altunçekiç Yıldırım, Arzu, vd. “Are serum GRP78 levels significant in chronic hepatitis C patients? A case-control study”. Journal of Surgery and Medicine, c. 3, sy 12, Aralık 2019, ss. 852-5, doi:10.28982/josam.595537.
Vancouver
1.Arzu Altunçekiç Yıldırım, Selma Cırrık, Yeliz Çetinkol, Mustafa Kerem Çalgın, Tevfik Noyan. Are serum GRP78 levels significant in chronic hepatitis C patients? A case-control study. J Surg Med. 01 Aralık 2019;3(12):852-5. doi:10.28982/josam.595537